Table 4.
Contrast between day- and night-time effects of rosiglitazone on ambulatory BP at 12 months
| Background metformin | Background sulfonylurea | |
| rosiglitazone vs sulfonylurea (difference (95% CI), p-value) | rosiglitazone vs metformin (difference (95% CI), p-value) | |
| Systolic BP (mmHg) | ||
| 24-hour | -2.7 (-4.9, -0.5), 0.016 | -2.5 (-4.8, -0.2), 0.031 |
| Day-time | -3.3 (-5.6, -1.0), 0.004 | -1.6 (-3.9, 0.9), NS |
| Night-time | -1.5 (-3.9, 1.0), NS | -4.0 (-6.6, -1.3), 0.004 |
| Diastolic BP (mmHg) | ||
| 24-hour | -2.1 (-3.4, -0.7), 0.003 | -3.1 (-4.5, -1.8), < 0.001 |
| Day-time | -2.5 (-3.9, -1.0), 0.001 | -2.5 (-3.9, -1.0), 0.001 |
| Night-time | -1.3 (-2.9, 0.3), NS | -4.0 (-5.7, -2.4), < 0.001 |